Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Change in Accured Expenses (2019 - 2025)

Outset Medical (OM) has disclosed Change in Accured Expenses for 7 consecutive years, with $3.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 273.16% to $3.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.7 million, a 42.67% decrease, with the full-year FY2025 number at -$2.7 million, down 42.67% from a year prior.
  • Change in Accured Expenses was $3.3 million for Q4 2025 at Outset Medical, up from $1.1 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $11.6 million in Q3 2022 to a low of -$11.5 million in Q1 2022.
  • A 5-year average of $30050.0 and a median of -$215500.0 in 2021 define the central range for Change in Accured Expenses.
  • Biggest YoY gain for Change in Accured Expenses was 2054.45% in 2022; the steepest drop was 7093.9% in 2022.
  • Outset Medical's Change in Accured Expenses stood at $5.0 million in 2021, then plummeted by 113.36% to -$665000.0 in 2022, then plummeted by 281.95% to -$2.5 million in 2023, then increased by 25.63% to -$1.9 million in 2024, then skyrocketed by 273.16% to $3.3 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Change in Accured Expenses are $3.3 million (Q4 2025), $1.1 million (Q3 2025), and -$4.3 million (Q2 2025).